Future of Implantable Devices for Cardiac Rhythm Management

The first cardiac implantable electronic device (CIED), the electronic pacemaker, maintains cardiac contraction during bradycardia. The implantable cardioverter-defibrillator (ICD) manages ventricular tachycardia (VT) or fibrillation (VF) and saves lives primarily through the use of high-energy shocks. The cardiac resynchronization therapy (CRT) device restores interventricular and intraventricular dyssynchrony in patients with heart failure (HF). Despite >50 years of pacing and 40 years of ICD therapy, the lead remains the weakest link between the device and the patient. Although CRT reduces mortality and morbidity in HF, it is applicable only to those patients with systolic left ventricular (LV) dysfunction and wide QRS complex, especially left bundle-branch block. At best, only 70% of such patients respond, and the majority of patients without left bundle-branch block or with nonsystolic HF derive no benefit from CRT. Early detection of worsening HF with implantable sensors enables corrective therapy to avert acute decompensated HF. Implantable cardiac monitors (ICMs) allow monitoring of arrhythmias such as atrial fibrillation (AF). Despite their efficacy at eliminating the risk of sudden cardiac death (SCD) in the highest-risk patient, ICDs currently have a limited role in reducing the overall burden of SCD, and ICM has the potential for early identification of asymptomatic subjects at risk of SCD to derive benefit from ICD. An increasing cause of SCD is pulseless electric activity (PEA), and alternative management other than defibrillation will be required. This review addresses the recent exciting development of CIEDs in response to these unmet clinical needs such as leadless and endocardial pacing, subcutaneous ICD (S-ICD), low-energy multistage electrotherapy for VT and AF, intermediate-strength stimulation for PEA, early detection of VT, sensors for HF monitoring, and novel therapies for arrhythmias and HF. ### Limitations of Cardiac Pacing With Current Pacemakers and CRT Despite the significant improvements in device longevity, reliability, size/profile, and ease of implantation over the last 50 years, implanting a pacemaker …

[1]  R. Erbel,et al.  Leadless Pacing of the Heart Using Induction Technology: A Feasibility Study , 2009, Pacing and clinical electrophysiology : PACE.

[2]  Brian Olshansky,et al.  Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. , 2008, Circulation.

[3]  Vadim V Fedorov,et al.  A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. , 2012, Journal of the American College of Cardiology.

[4]  L. Jordaens,et al.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.

[5]  M. Zile,et al.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.

[6]  T. Sugiura,et al.  Feasibility of using the automatic generating system for quartz watches as a leadless pacemaker power source , 1999, Medical & Biological Engineering & Computing.

[7]  R. E. Riley,et al.  Feasibility and safety of a novel technology for pacing without leads. , 2006, Heart rhythm.

[8]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[9]  C. Lau,et al.  Bioartificial Sinus Node Constructed via In Vivo Gene Transfer of an Engineered Pacemaker HCN Channel Reduces the Dependence on Electronic Pacemaker in a Sick-Sinus Syndrome Model , 2006, Circulation.

[10]  D. Deno,et al.  Electrical therapy for post defibrillatory pulseless electrical activity. , 2004, Resuscitation.

[11]  M. Gold,et al.  Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial. , 2011, Congestive heart failure.

[12]  William T. Abraham,et al.  Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.

[13]  Catherine Klersy,et al.  Endocardial Left Ventricular Pacing Improves Cardiac Resynchronization Therapy in Chronic Asynchronous Infarction and Heart Failure Models , 2012, Circulation. Arrhythmia and electrophysiology.

[14]  J. Daubert,et al.  Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. , 2005, Journal of the American College of Cardiology.

[15]  C. Morillo,et al.  Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. , 2013, JAMA internal medicine.

[16]  David Begley,et al.  Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. , 2012, Journal of the American College of Cardiology.

[17]  S Adler,et al.  Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. , 2001, European heart journal.

[18]  Gerhard Hindricks,et al.  Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial , 2010, Circulation. Arrhythmia and electrophysiology.

[19]  A. Lichtenberg,et al.  Residual alpha-gal epitope content and elasticity of crosslinked vs. decellularized bovine pericardium , 2012 .

[20]  Peter Jung,et al.  Leadless pacing using induction technology: impact of pulse shape and geometric factors on pacing efficiency. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  W. Frishman,et al.  Rheos: An Implantable Carotid Sinus Stimulation Device for the Nonpharmacologic Treatment of Resistant Hypertension , 2011, Cardiology in review.

[22]  M. Rosen,et al.  Wild-Type and Mutant HCN Channels in a Tandem Biological-Electronic Cardiac Pacemaker , 2006, Circulation.

[23]  C. Jøns,et al.  Treating Cardiac Arrhythmias Detected With an Implantable Cardiac Monitor in Patients After an Acute Myocardial Infarction , 2012, Current Treatment Options in Cardiovascular Medicine.

[24]  Catherine Klersy,et al.  Left Ventricular Endocardial Pacing Improves Resynchronization Therapy in Canine Left Bundle-Branch Hearts , 2009, Circulation. Arrhythmia and electrophysiology.

[25]  Jagmeet P. Singh,et al.  Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  F. Leclercq,et al.  Left Ventricular Lead Insertion Using a Modified Transseptal Catheterization Technique: A Totally Endocardial Approach for Permanent Biventricular Pacing in End‐Stage Heart Failure , 1999, Pacing and clinical electrophysiology : PACE.

[27]  L. Eckardt,et al.  Shock Efficacy of Subcutaneous Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death: Initial Multicenter Experience , 2012, Circulation. Arrhythmia and electrophysiology.

[28]  R B Robinson,et al.  HCN2 Overexpression in Newborn and Adult Ventricular Myocytes: Distinct Effects on Gating and Excitability , 2001, Circulation research.

[29]  Markus Zabel,et al.  Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. , 2011, European heart journal.

[30]  C. Vassanelli,et al.  Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[31]  Wanchun Tang,et al.  Coronary Blood Flow Produced by Muscle Contractions Induced by Intracardiac Electrical CPR during Ventricular Fibrillation , 2009, Pacing and clinical electrophysiology : PACE.

[32]  L. Gepstein,et al.  A combined gene and cell therapy approach for restoration of conduction. , 2011, Heart rhythm.

[33]  E. Warburton,et al.  Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke , 2013, Neurology.

[34]  J. O. Oteo Domínguez,et al.  Influence of the implantable cardioverter-defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. , 1997, Circulation.

[35]  Daniel J. Inman,et al.  Abstract 15551: Vibration Powered Cardiac Rhythm Devices , 2012 .

[36]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[37]  A. Yue,et al.  Targeted left ventricular endocardial pacing using a steerable introducing guide catheter and active fixation pacing lead. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[38]  D. Burkhoff,et al.  A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. , 2011, American heart journal.

[39]  Rona Shofti,et al.  Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.

[40]  A. Turley,et al.  Video-assisted thoracoscopic left ventricular pacing in patients with and without previous sternotomy. , 2013, The Annals of thoracic surgery.

[41]  H. Tan,et al.  Implantable Cardioverter-Defibrillators Have Reduced the Incidence of Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Lethal Arrhythmias , 2012, Circulation.

[42]  J. W. Spickler,et al.  Totally self-contained intracardiac pacemaker. , 1970, Journal of electrocardiology.

[43]  R. Cappato,et al.  Development of an entirely subcutaneous implantable cardioverter-defibrillator. , 2012, Progress in cardiovascular diseases.

[44]  S. Chugh,et al.  Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block. , 2012, Heart rhythm.

[45]  Suneet Mittal,et al.  Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchron , 2010, Circulation.

[46]  P. Binkley,et al.  Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients , 2012, Journal of Interventional Cardiac Electrophysiology.

[47]  D. Zipes,et al.  Spinal Cord Stimulation Improves Ventricular Function and Reduces Ventricular Arrhythmias in a Canine Postinfarction Heart Failure Model , 2009, Circulation.

[48]  Hung-Fat Tse,et al.  First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices. , 2007, Journal of the American College of Cardiology.

[49]  M. Kroll,et al.  Medium voltage therapy for preventing and treating asystole and PEA in ICDs , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[50]  Martin Baruch,et al.  Utility of a novel watch-based pulse detection system to detect pulselessness in human subjects. , 2011, Heart rhythm.

[51]  D. Mark,et al.  Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.

[52]  Nicolas Derval,et al.  Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. , 2010, Journal of the American College of Cardiology.

[53]  J. Hartikainen,et al.  Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study , 2010, Circulation.

[54]  Martin Borggrefe,et al.  Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. , 2012, American heart journal.

[55]  M. Chung,et al.  Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.

[56]  Thomas Schmitz-Rode,et al.  A Novel Fully Implantable Wireless Sensor System for Monitoring Hypertension Patients , 2012, IEEE Transactions on Biomedical Engineering.

[57]  P. Schauerte,et al.  Intracardiac impedance monitors stroke volume in resynchronization therapy patients. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[58]  J. Barat,et al.  Endocardial biventricular pacing. , 2000, Pacing and clinical electrophysiology : PACE.

[59]  Laura Cercenelli,et al.  Validation of a peak endocardial acceleration-based algorithm to optimize cardiac resynchronization: early clinical results , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[60]  Sana M. Al-Khatib,et al.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[61]  L. Jordaens,et al.  Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. , 2012, American heart journal.

[62]  Jens Jordan,et al.  Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. , 2010, Journal of the American College of Cardiology.

[63]  A. Chandrakasan,et al.  Energy extraction from the biologic battery in the inner ear , 2012, Nature Biotechnology.

[64]  Eduardo Marbán,et al.  Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. , 2003, The Journal of clinical investigation.

[65]  F. Romeo,et al.  Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes , 2011, Heart.

[66]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[67]  Stefan Sack,et al.  A novel method--the activity log index--for monitoring physical activity of patients with heart failure. , 2002, The American journal of cardiology.

[68]  J. Till,et al.  Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. , 2012, European heart journal.

[69]  M. Josephson,et al.  Molecular enhancement of porcine cardiac chronotropy , 2001, Heart.

[70]  J. Triedman,et al.  System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. , 2010, Heart rhythm.

[71]  Martin J Schalij,et al.  Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. , 2011, Journal of the American College of Cardiology.

[72]  T van der Nagel,et al.  Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops. , 2004, The Journal of thoracic and cardiovascular surgery.

[73]  M. Gold,et al.  Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.

[74]  Jagmeet P. Singh,et al.  Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. , 2012, European heart journal.

[75]  G. Fonarow,et al.  Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. , 1997, Circulation.

[76]  L. Eckardt,et al.  Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. , 2013, Heart rhythm.

[77]  M. Biel,et al.  Dominant-Negative Suppression of HCN Channels Markedly Reduces the Native Pacemaker Current If and Undermines Spontaneous Beating of Neonatal Cardiomyocytes , 2003, Circulation.

[78]  G. Lip,et al.  Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. , 2009, American heart journal.

[79]  Vadim V Fedorov,et al.  Low-Energy Multistage Atrial Defibrillation Therapy Terminates Atrial Fibrillation With Less Energy Than a Single Shock , 2011, Circulation. Arrhythmia and electrophysiology.

[80]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[81]  W. Maisel,et al.  Implantable cardioverter-defibrillator lead performance. , 2008, Circulation.

[82]  L. Mitchell,et al.  Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. , 2002, Journal of the American College of Cardiology.

[83]  Maurizio Marzegalli,et al.  Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.

[84]  J. Floras,et al.  Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. , 2009, Journal of the American College of Cardiology.

[85]  Wojciech Zareba,et al.  Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.

[86]  M. Borggrefe,et al.  Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.

[87]  C. Siu,et al.  Thoracic Spinal Cord Stimulation Improves Cardiac Contractile Function and Myocardial Oxygen Consumption in a Porcine Model of Ischemic Heart Failure , 2012, Journal of cardiovascular electrophysiology.

[88]  Igor R Efimov,et al.  Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction. , 2009, Heart rhythm.

[89]  C. Lau,et al.  Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on the acoustic window. , 2009, Heart rhythm.

[90]  Alexander H Maass,et al.  An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.

[91]  David A. Kass,et al.  Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[92]  Eugene Crystal,et al.  Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. , 2010, Journal of the American College of Cardiology.

[93]  Hee Cheol Cho,et al.  Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18 , 2012, Nature Biotechnology.

[94]  K. Ellenbogen,et al.  Downloadable Software Algorithm Reduces Inappropriate Shocks Caused by Implantable Cardioverter-Defibrillator Lead Fractures: A Prospective Study , 2010, Circulation.

[95]  C. Lau,et al.  Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.

[96]  A. Natale,et al.  Closed Loop Stimulation is Effective in Improving Heart Rate and Blood Pressure Response to Mental Stress: Report of a Single‐Chamber Pacemaker Study in Patients with Chronotropic Incompetent Atrial Fibrillation , 2012, Pacing and clinical electrophysiology : PACE.

[97]  J. Kautzner,et al.  Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: Retrospective study with 1 year follow up , 2012, BMC Cardiovascular Disorders.

[98]  L. Piegas,et al.  The Guardian: an implantable system for chronic ambulatory monitoring of acute myocardial infarction. , 2009, Journal of electrocardiology.

[99]  P. Schwartz Vagal stimulation for the treatment of heart failure: a translational success story , 2012, Heart.

[100]  T. Walther,et al.  Endurance and Performance of Two Different Concepts for Left Ventricular Stimulation with Bipolar Epicardial Leads in Long-Term Follow-Up , 2010, Thoracic and Cardiovascular Surgeon.

[101]  D. Zipes,et al.  Thoracic Spinal Cord Stimulation Reduces the Risk of Ischemic Ventricular Arrhythmias in a Postinfarction Heart Failure Canine Model , 2005, Circulation.

[102]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[103]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[104]  K. Ellenbogen,et al.  An alternative technique of implanting a nontransvenous implantable cardioverter-defibrillator system in adults with no or limited venous access to the heart. , 2010, Heart rhythm.